Holen Sie sich die Stockscreener-App
78.32
0.54%
0.4187
Handel nachbörslich:
78.35
0.0313
+0.04%
Schlusskurs vom Vortag:
$77.90
Offen:
$79.32
24-Stunden-Volumen:
3,319
Relative Volume:
0.60
Marktkapitalisierung:
$281.93M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.88%
1M Leistung:
+7.04%
6M Leistung:
+23.65%
1J Leistung:
+15.78%
1-Tages-Spanne:
$78.28
$79.58
1-Wochen-Bereich:
$76.78
$79.58
52-Wochen-Spanne:
$54.52
$79.58
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
Firmenname
Invesco Biotechnology Genome Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PBE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBE
Invesco Biotechnology Genome Etf
|
78.32 | 281.93M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
320.10 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
652.53 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
655.77 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
241.32 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
585.67 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf Aktie (PBE) Neueste Nachrichten
Genome ETF stock announce special dividendWeekly Trade Summary & Stepwise Entry and Exit Trade Signals - newser.com
Genome ETF stock considered safe havenJuly 2025 Setups & Stepwise Trade Signal Implementation - newser.com
2 ETFs to Watch for Outsized Volume on Biotechnology Stocks - TradingView
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Invesco Biotechnology & Genome ETF declares quarterly distribution of $0.2341 - MSN
Genome ETF stock compared to rivalsJuly 2025 News Drivers & Precise Swing Trade Alerts - Trung tâm Dự báo KTTV quốc gia
Genome ETF stockChart Signals & Fast Exit and Entry Trade Guides - newser.com
Wealth Enhancement Advisory Services LLC Sells 2,491 Shares of Invesco Biotechnology & Genome ETF $PBE - Defense World
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - sharewise.com
Genome ETF stock benefit from mergersTrade Risk Summary & Consistent Return Strategy Ideas - newser.com
The Best Biotech ETFs to Buy - Kiplinger
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - MSN
Genome ETF stock deliver strong annual returnsJuly 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - Benzinga
Signet Financial Management LLC Grows Position in Invesco Biotechnology & Genome ETF $PBE - Defense World
Invesco Biotechnology & Genome ETF $PBE Position Decreased by HighTower Advisors LLC - Defense World
7 Best Biotech ETFs to Buy Now - US News Money
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Sold by LPL Financial LLC - Defense World
Cetera Investment Advisers Has $1.34 Million Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Acquired by Private Advisor Group LLC - Defense World
Invesco (IVZ) Rallies 0.18% to Highest Since July 2025 Amid Asset Management Sector Reassessment - AInvest
PBE ETF: A Comprehensive Guide to Its Fundamentals and Performance - AInvest
Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RSPF)? - Yahoo Finance
Invesco Nasdaq Biotechnology ETF IBBQ 2025Q2 Earnings Preview Upside Potential on Biotech Sector Growth - AInvest
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Purchased by Wealth Enhancement Advisory Services LLC - Defense World
Janney Montgomery Scott LLC Has $344,000 Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco Exchange-Traded Fund TrustInvesco Biotechnology & Genome ETF Reports Earnings Results for the Full Year Ended April 30, 2025 - MarketScreener
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Short Interest Update - Defense World
Farther Finance Advisors LLC Acquires 6,201 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Wealth Enhancement Advisory Services LLC Raises Stake in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Two Sigma Investments LP Cuts Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
PDS Biotechnology (NASDAQ:PDSB) Receives Buy Rating from HC Wainwright - Defense World
Citadel Advisors LLC Grows Stake in Innovator U.S. Equity Ultra Buffer ETF – January (BATS:UJAN) - Defense World
8,551 Shares in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Acquired by Citadel Advisors LLC - Defense World
Bank of America Corp DE Has $4.59 Million Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Stake Lessened by Cetera Investment Advisers - Defense World
Finanzdaten der Invesco Biotechnology Genome Etf-Aktie (PBE)
Es liegen keine Finanzdaten für Invesco Biotechnology Genome Etf (PBE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):